There are some forgotten items. There is
a
specific way to eradicate cancer
cells at the very early stage of their appearance. Natural humoral immunity with CD5+ B-cell produced pentameric IgM to cancer associated glycans normally
to
eliminate arising cancer cells. This branch of innate immunity is decreasing with age and that is a basis for selective immunodeficieny which may be corrected. This area of research was well studied and proved by the team of Prof. Vollmers (Germany), but then forgotten for about 15 years.
Natural B-Cell Immunity Cancer Prevention IgM Anti-GlycansConflicts of Interest
The author declares no conflicts of interest regarding the publication of this paper.
Cite this paper
Tupitsyn, N. (2021) Central Role of Innate B-Cell Immunity in Cancer Prevention. Advances in Biological Chemistry, 11, 12-14. https://doi.org/10.4236/abc.2021.111002
ReferencesDavydov M.I. ,et al. (2017)There is No Cancer Immunology, It is Mere Infectional Immunology Haematopoiesis Immunology 15, 10-11.Brandlein, S., Pohle, T., Ruoff, N., Wozniak, E., Muller-Hermelink, H.K. and Vollmers, H.P. (2003) Natural IgM Antibodies and Immunosurveillance Mechanisms against Epithelial Cancer Cells in Humans. Cancer Research, 63, 7995-8005.Pohle, T., Brandlein, S., Ruoff, N., Muller-Hermelink, H.K. and Vollmers, H.P. (2004) Lipoptosis: Tumor-Specific Cell Death by Antibody-Induced Intercellular Lipid Accumulation. Cancer Research, 64, 3900-3906.
https://doi.org/10.1158/0008-5472.CAN-03-3149Brandlein, S., Rauschert, N., Rasche, L., Dreykluft, A., Hensel, F., Conzelmann, E., Muller-Hermelink, H.K. and Vollmers, H.P. (2007) The Human IgM Antibody SAM-6 Induces Tumor-Specific Apoptosis with Oxidized Low-Density Lipoprotein. Molecular Cancer Therapeutics, 6, 326-333.
https://doi.org/10.1158/1535-7163.MCT-06-0399Tupitsyn, N.N., Galanina, O.T., Bovin, N.V, Gadetskaya, N.A., Shelepova, V.M., Korotkova, O.V. and Kadagidze, Z.G. (2008) Level of Specific Antibodies to Glycan LeC is Diminished in Breast Cancer Patients. Immunologia, 2, 31-33.Tupitsyn, N.N., Udalova, Y.A., Galanina, O.E., Kadagidze, Z.G., Borovkova, N.B., Podolsky, V.V., Shinkarev, S.A., Gadetskaya, N.A., Letyagin, V.P., Obukhova, P.S., Shilova, N.V., Subbotina, A.A. and Bovin, N.V. (2009) Tumor-Associated Glycan Lewis C in Breast Cancer. Haematopoiesis Immunology, 6, 45-54.Huflejt, M. (2019) Glyco-Immuno-Oncology: From Diagnosis to Treatment Opportunities. http://imhaemo.ru/media/documents/HI_16/28_16.pdfIllert, B., Otto, C., Vollmers, H.P., Hensel, F., Thiede, A. and Timmermann, W. (2005) Human Antibody SC-1 Reduces Disseminated Tumor Cells in Nude Mice with Human Gastric Cancer. Oncology Reports, 13, 765-770.
https://doi.org/10.3892/or.13.4.765Zheng, H., Bae, Y., Kasimir-bauer, S., Tang, R., Chen, J., Ren, G., Yuan, M., Esposito, M., Li, W., Mei, Y., Shen, M., Zhang, L., Tupitsyn, N., Pantel, K., King, C., Sun, J., Moriguchi, J., Jun, H.T., Coxon, A., Lee, B. and Kang, Y. (2017) Therapeutic Antibody Targeting Tumor and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy. Cancer Cell, 32, 731-747.
https://doi.org/10.1016/j.ccell.2017.11.002Chernysheva, O., Markina, I., Demidov, L., Kupryshina, L., Chulkova, S., Palladina, A., Antipova, A. and Tupitsyn, N. (2019) Bone Marrow Involvement in Melanoma. Potentials for Detection of Disseminated Tumor Cells and Characterization of Their Subsets by Flow Cytometry. Cells, 8, 627. https://doi.org/10.3390/cells8060627
https://www.mdpi.com/journal/cellsAlexia, C., Cren, M., Louis-Prence, P., Vo, D.N., El-Ahmadi, Y., Dufourcq-Lopez, E., Lu, Z., Hernandez, J., Shamilov, F., Chernysheva, O., Vasilieva, M., Vorotnikov, I., Vishnevskay, Y., Tupitsyn, N., Rossi, J.F. and Villaba, M. (2019) Polyoxidonium Activates Cytotoxic Lymphocyte Responses through Dendritic Cell Maturation: Clinical Effects in Breast Cancer. Frontiers in Immunology, 10, 2693.
https://doi.org/10.3389/fimmu.2019.02693